Deutsch English Français

Contact

EP2386861

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2386861

EP2386861 - Cross-ß structure binding compounds [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 14.06.2013 Database last updated on 02.09.2024
Most recent event Tooltip	14.06.2013	Application deemed to be withdrawn	published on 17.07.2013 [2013/29]
Applicant(s)	For all designated states Crossbeta Biosciences B.V. Padualaan 8 3584 CH Utrecht / NL
	[2011/46]
Inventor(s)	01 / Gebbink, Martijn Frans Ben Gerard Zaadkorrel 34 3755 HL Eemnes / NL
	02 / Bouma, Barend Tappersgilde 3 3994 CE Houten / NL
	[2011/46]
Representative(s)	Raggers, René John, et al Exter Polak & Charlouis B.V. P.O. Box 3241 2280 GE Rijswijk / NL
	[2011/46]
Application number, filing date	11153446.7	13.07.2006
	[2011/46]
Priority number, date	EP20050076613	13.07.2005 Original published format: EP 05076613
	[2011/46]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP2386861
	Date:	16.11.2011
	Language:	EN
	[2011/46]
	Type:	A3 Search report
	No.:	EP2386861
	Date:	18.07.2012
	Language:	EN
	[2012/29]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	14.06.2012
Classification	IPC:	G01N33/68, A61P43/00, A61K31/00, A61K39/395	[2011/46]
	CPC:	G01N33/6896 (EP,US); A61P43/00 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/46]
Title	German:	Cross-Beta-Struktur-bindende Verbindungen	[2011/46]
	English:	Cross-ß structure binding compounds	[2011/46]
	French:	Composés de liaison à structure ß croisée	[2011/46]
Examination procedure	04.02.2011	Examination requested [2011/46]
	19.01.2013	Application deemed to be withdrawn, date of legal effect [2013/29]
	26.02.2013	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/29]
Parent application(s) Tooltip	EP06783842.5 / EP1910844
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060783842) is 04.02.2009
Fees paid	Renewal fee
	04.02.2011	Renewal fee patent year 03
	04.02.2011	Renewal fee patent year 04
	04.02.2011	Renewal fee patent year 05
	28.07.2011	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	31.07.2012	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XI]WO03073106 (MICROSENS BIOPHAGE LTD [GB], et al) [X] 1,2,4 * page 7, lines 14-26; examples 10,13 * [I] 3,5-9;
		[XI]US2003236391 (KLUNK WILLIAM E [US], et al) [X] 1-3,5,7 * paragraph [0130] *[I] 4,6,8,9;
		[XI]EP1380290 (UNIV MEDISCH CENTRUM UTRECHT [NL], et al) [X] 1-3,5,7,8 * paragraphs [0016] , [0 28] , [0 54] , [0 56] , [0 73] , [0 78] , [0 91] - [0059] - [0027] , [0053] , [0054] , [0057] , [0058] , [0073] - [0078]; figures 7,9; claims 28,33,36,37,40 * * paragraphs [0009] , [0 75] - [0076] - [0 34] * [I] 4,6,9;
		[AD] - O'NUALLAIN BRIAN ET AL, "Conformational Abs recognizing a generic amyloid fibril epitope", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (20020205), vol. 99, no. 3, ISSN 0027-8424, pages 1485 - 1490, XP002211263 [AD] 1-9 * page 1486, column 2, paragraph 2 - page 1487, column 1, paragraph 1; figure 4 * * page 1485, column 1, lines 6-7 * DOI: http://dx.doi.org/10.1073/pnas.022662599
		[XI] - CARDOSO I ET AL, "APROTININ BINDING TO AMYLOID FIBRILS", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, (200004), vol. 267, no. 8, ISSN 0014-2956, pages 2307 - 2311, XP001128718 [X] 1-3,7 * page 2311, paragraph L * * page 2310, column 1, paragraph 1 * * page 2308, column 1, paragraph 2 * * page 2308, column 2, paragraph 2 * * page 2309, column 1, paragraphs 4-5 * [I] 4-6,8,9 DOI: http://dx.doi.org/10.1046/j.1432-1327.2000.01237.x
		[XDI] - KRANENBURG D ET AL, "TISSUE-TYPE PLASMINOGEN ACTIVATOR IS A MULTILIGAND CROSS-BETA STRUCTURE RECEPTOR", CURRENT BIOLOGY, CURRENT SCIENCE, GB, (20021029), vol. 12, no. 21, doi:10.1016/S0960-9822(02)01224-1, ISSN 0960-9822, pages 1833 - 1839, XP001172448 [XD] 1,2,4 * figure 4 * [I] 3,5-9 DOI: http://dx.doi.org/10.1016/S0960-9822(02)01224-1
		[XI] - HINTERSTEINER M ET AL, "IN VIVO DETECTION OF AMYLOID-BETA DEPOSITS BY NEAR-INFRARED IMAGING USING AN OXAZINE-DERIVATIVE PROBE", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20050501), vol. 23, no. 5, doi:10.1038/NBT1085, ISSN 1087-0156, pages 577 - 583, XP008061625 [X] 1-4,6 * page 583, column 1, paragraph 2 * [I] 5,7-9 DOI: http://dx.doi.org/10.1038/nbt1085
	by applicant	AU2003214375
		WO2004004698
		- BOUMA,B.; KROON-BATENBURG LM; WU YP ET AL., "Glycation induces formation of amyloid cross-beta structure in albumin", J. BIOL. CHEM., (2003), vol. 278, pages 41810 - 41819
		- TOWNSEND,K.P. ET AL., "CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide", EUR. J. IMMUNOL., (2005), vol. 35, pages 901 - 910
		- SUBANG,R. ET AL., "Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies", J. AUTOIMMUN., (2000), vol. 15, pages 21 - 32
		- KRANENBURG,O.; BOUMA B; KROON-BATENBURG LM ET AL., "Tissue-type plasminogen activator is a multiligand cross-beta structure receptor", CURR. BIOL., (2002), vol. 12, pages 1833 - 1839
		- GEBBINK,M.F.; CLAESSEN,D.; BOUMA,B.; DIJKHUIZEN,L.; WOSTEN,H.A., "Amyloids--a functional coat for microorganisms", NAT. REV. MICROBIOL., (2005), vol. 3, pages 333 - 341
		- SCHOUSBOE,!, "Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+", BLOOD COAGUL. FIBRINOLYSIS, (1997), vol. 8, pages 97 - 104
		- O'NUALLAIN,B.; WETZEL,R., "Conformational Abs recognizing a generic amyloid fibril epitope", PROC. NATL. ACAD. SCI. U. S. A, (2002), vol. 99, pages 1485 - 1490
		- KAYED,R. ET AL., "Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis", SCIENCE, (2003), vol. 300, pages 486 - 489
		- MATZINGER,P., "The danger model: a renewed sense of self", SCIENCE, (2002), vol. 296, pages 301 - 305
		- ASHKAR,A.A.; ROSENTHAL,K.L., "Toll-like receptor 9, CpG DNA and innate immunity", CURR. MOL. MED., (2002), vol. 2, pages 545 - 556
		- SARVARI,M. ET AL., "Inhibition of Clq-beta-amyloid binding protects hippocampal cells against complement mediated toxicity", J. NEUROIMMUNOL., (2003), vol. 137, pages 12 - 18
		- VEERHUIS,R. ET AL., "Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and Clq", NEUROBIOL. DIS., (2005), vol. 19, pages 273 - 282
		- BELLOTTI,V.; MANGIONE,P.; MERLINI,G., "Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability", J. STRUCT. BIOL., (2000), vol. 130, pages 280 - 289
		- BUXBAUM,J.N., "The systemic amyloidoses", CURR. OPIN. RHEUMATOL., (2004), vol. 16, pages 67 - 75
		- HORBACH,D.A.; VAN OORT,E.; DONDERS,R.C.; DERKSEN,R.H.; DE GROOT,P.G., "Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies", THROMB. HAEMOST., (1996), vol. 76, pages 916 - 924
		- HORBACH,D.A.; VAN OORT,E.; TEMPELMAN,M.J.; DERKSEN,R.H.; DE GROOT,P.G., "The prevalence of a non-phospholipid-binding form ofbeta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies", THROMB. HAEMOST., (1998), vol. 80, pages 791 - 797
		- DE LAAT,H.B.; DERKSEN,R.H.; URBANUS,R.T.; ROEST,M.; DE GROOT,P.G., "beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome", BLOOD, (2004), vol. 104, pages 3598 - 3602
		- CONNOR,P.; HUNT,B.J., "Cerebral haemostasis and antiphospholipid antibodies", LUPUS, (2003), vol. 12, pages 929 - 934
		- DE GROOT,P.G.; HORBACH,D.A.; DERKSEN,R.H., "Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis", LUPUS, (1996), vol. 5, pages 488 - 493
		- MATSUURA,E.; IGARASHI,Y.; YASUDA,T.; TRIPLETT,D.A.; KOIKE,T., "Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface", J. EXP. MED., (1994), vol. 179, pages 457 - 462
		- LEVINE,J.S.; SUBANG,R.; KOH,J.S.; RAUCH,J., "Induction of anti- phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes", J. AUTOIMMUN., (1998), vol. 11, pages 413 - 424
		- KUWANA,M., "Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity", THROMB. RES., (2004), vol. 114, pages 347 - 355
		- KUWANA,M. ET AL., "Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells", BLOOD, (2005), vol. 105, pages 1552 - 1557
		- MATZINGER,P., "An innate sense of danger", ANN. N. Y. ACAD. SCI., (2002), vol. 961, pages 341 - 342
		- BOUMA,B. ET AL., "Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure", EMBO J., (1999), vol. 18, pages 5166 - 5174
		- SCHIELEN,W.J.; ADAMS,H.P.; VOSKUILEN,M.; TESSER,G.I., "Nieuwenhuizen,W. The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen", BLOOD COAGUL. FIBRINOLYSIS, (1991), vol. 2, pages 465 - 470
		- NELSON,R. ET AL., "Structure of the cross-beta spine of amyloid-like fibrils", NATURE, (2005), vol. 435, pages 773 - 778
		- KRANENBURG 0; BOUMA B; GENT YY ET AL., "Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation", MOL CELL NEUROSCI., (2005), vol. 28, pages 496 - 508

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p